118 related articles for article (PubMed ID: 10348370)
1. Proteosome delivery of a protective 9B-antigen against Schistosoma mansoni.
Tarrab-Hazdai R; Schechtman D; Lowell G; Pirak E; Arnon R
Int J Immunopharmacol; 1999 Mar; 21(3):205-18. PubMed ID: 10348370
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of a protective peptide-based vaccine against Schistosoma mansoni.
Tarrab-Hazdai R; Schechtman D; Arnon R
Infect Immun; 1998 Sep; 66(9):4526-30. PubMed ID: 9712813
[TBL] [Abstract][Full Text] [Related]
3. A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice.
Pinheiro CS; Ribeiro AP; Cardoso FC; Martins VP; Figueiredo BC; Assis NR; Morais SB; Caliari MV; Loukas A; Oliveira SC
Parasite Immunol; 2014 Jul; 36(7):303-12. PubMed ID: 24749785
[TBL] [Abstract][Full Text] [Related]
4. Protective capacity of cercarial transformation fluid alone or in combination with crude cercarial antigen against challenge infections of Schistosoma mansoni in mice.
El Azzouni MZ; Mady RF; Gaafar MR; Arafa FM; Elhadidi A
J Helminthol; 2017 Jan; 91(1):35-42. PubMed ID: 26817577
[TBL] [Abstract][Full Text] [Related]
5. A mimotope peptide-based vaccine against Schistosoma mansoni: synthesis and characterization.
Arnon R; Tarrab-Hazdai R; Steward M
Immunology; 2000 Dec; 101(4):555-62. PubMed ID: 11122460
[TBL] [Abstract][Full Text] [Related]
6. Protective immunity in baboons vaccinated with a recombinant antigen or radiation-attenuated cercariae of Schistosoma mansoni is antibody-dependent.
Soisson LA; Reid GD; Farah IO; Nyindo M; Strand M
J Immunol; 1993 Nov; 151(9):4782-9. PubMed ID: 8409436
[TBL] [Abstract][Full Text] [Related]
7. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection.
Cardoso FC; Macedo GC; Gava E; Kitten GT; Mati VL; de Melo AL; Caliari MV; Almeida GT; Venancio TM; Verjovski-Almeida S; Oliveira SC
PLoS Negl Trop Dis; 2008 Oct; 2(10):e308. PubMed ID: 18827884
[TBL] [Abstract][Full Text] [Related]
8. Antibodies are involved in the protective immunity induced in mice by Schistosoma mansoni schistosomula tegument (Smteg) immunization.
Melo TT; Sena IC; Araujo N; Fonseca CT
Parasite Immunol; 2014 Feb; 36(2):107-11. PubMed ID: 24558655
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Schistosoma mansoni 44.7/56.8 kDa egg antigens recognized by human monoclonal antibodies which induce protection against experimental infection and proliferation of peripheral blood mononuclear cells from schistosomiasis patients.
Hirsch C; Almeida CA; Doughty BL; Goes AM
Vaccine; 1997 Jun; 15(9):948-54. PubMed ID: 9261940
[TBL] [Abstract][Full Text] [Related]
10. Lacto-N-fucopentaose III (Lewis x), a target of the antibody response in mice vaccinated with irradiated cercariae of Schistosoma mansoni.
Richter D; Incani RN; Harn DA
Infect Immun; 1996 May; 64(5):1826-31. PubMed ID: 8613397
[TBL] [Abstract][Full Text] [Related]
11. Vaccination against Schistosoma mansoni infection using 74 kDa Schistosoma protein antigen.
Attallah AM; Attia H; Ismail H; Yones E; El-Nashar EM; Abd El-Kader K; Tabll A; Saad A; Sultan A
Vaccine; 1999 Jul; 17(22):2786-91. PubMed ID: 10438048
[TBL] [Abstract][Full Text] [Related]
12. A Strong Humoral Immune Response Induced by a Vaccine Formulation Containing rSm29 Adsorbed to Alum Is Associated With Protection Against
Alves CC; Araujo N; Bernardes WPOS; Mendes MM; Oliveira SC; Fonseca CT
Front Immunol; 2018; 9():2488. PubMed ID: 30450095
[TBL] [Abstract][Full Text] [Related]
13. Schistosome syntenin partially protects vaccinated mice against Schistosoma mansoni infection.
Figueiredo BC; Assis NR; Morais SB; Ricci ND; Pinheiro CS; Martins VP; Bicalho RM; Da'dara AA; Skelly PJ; Oliveira SC
PLoS Negl Trop Dis; 2014 Aug; 8(8):e3107. PubMed ID: 25144756
[TBL] [Abstract][Full Text] [Related]
14. Schistosoma mansoni phosphofructokinase: immunolocalization in the tegument and immunogenicity.
Mansour JM; McCrossan MV; Bickle QD; Mansour TE
Parasitology; 2000 May; 120 ( Pt 5)():501-11. PubMed ID: 10840980
[TBL] [Abstract][Full Text] [Related]
15. Schistosoma mansoni schistosomula tegument (Smteg) immunization in absence of adjuvant induce IL-10 production by CD4+ cells and failed to protect mice against challenge infection.
Araujo JM; de Melo TT; de Sena IC; Alves CC; Araujo N; Durães Fdo V; Oliveira SC; Fonseca CT
Acta Trop; 2012 Nov; 124(2):140-6. PubMed ID: 22842304
[TBL] [Abstract][Full Text] [Related]
16. Protective monoclonal antibody against Schistosoma mansoni: antigen isolation, characterization, and suitability for active immunization.
Hazdai RT; Levi-Schaffer F; Brenner V; Horowitz S; Eshhar Z; Arnon R
J Immunol; 1985 Oct; 135(4):2772-9. PubMed ID: 4031500
[TBL] [Abstract][Full Text] [Related]
17. Intranasal administration of synthetic recombinant peptide-based vaccine protects mice from infection by Schistosoma mansoni.
Ben-Yedidia T; Tarrab-Hazdai R; Schechtman D; Arnon R
Infect Immun; 1999 Sep; 67(9):4360-6. PubMed ID: 10456875
[TBL] [Abstract][Full Text] [Related]
18. Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen.
Pearce EJ; James SL; Hieny S; Lanar DE; Sher A
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5678-82. PubMed ID: 3135553
[TBL] [Abstract][Full Text] [Related]
19. Candidate vaccine antigens that stimulate the cellular immune response of mice vaccinated with irradiated cercariae of Schistosoma mansoni.
Richter D; Reynolds SR; Harn DA
J Immunol; 1993 Jul; 151(1):256-65. PubMed ID: 8326127
[TBL] [Abstract][Full Text] [Related]
20. The influence of adjuvant on induction of protective immunity by a non-living vaccine against schistosomiasis.
James SL; Pearce EJ
J Immunol; 1988 Apr; 140(8):2753-9. PubMed ID: 3128608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
